• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[头孢菌素类和碳青霉烯类对临床分离脓肿分枝杆菌的活性]

[Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus].

作者信息

Ito Kunihiko, Hashimoto Kenichi, Ogata Hideo

机构信息

Research Division, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, 3-1-24, Matsuyama, Kiyose-shi, Tokyo 204-8533, Japan.

出版信息

Kekkaku. 2003 Sep;78(9):587-90.

PMID:14577345
Abstract

To screen effective useful drugs for disease due to M. abscessus, we determined MIC of 3 cephems [ceftazidime (CAZ), cefoxitin (CFX), flomoxef (FMOX)] and 3 carbapenems [imipenem (IPM), panipenem (PAPM), meropenem (MEPM)] for 8 strains of clinically isolated M. abscessus by micro-dilution method using MGIT system. In all the 8 strains, MICs of CAZ are higher than 32 micrograms/ml. MIC50, MIC90, MIC range of CFX are 32 micrograms/ml, > 32 micrograms/ml and 16- > 32 micrograms/ml respectively, and for FMOX, 16 micrograms/ml, 32 micrograms/ml and 16-32 micrograms/ml; for IPM, 8 micrograms/ml, 16 micrograms/ml and 8-16 micrograms/ml; for PAPM, 4 micrograms/ml, 16 micrograms/ml and 4-16 micrograms/ml; for MEPM, 8 micrograms/ml, 16 micrograms/ml and 8-16 micrograms/ml. From this study, it is concluded that FMOX, IPM, PAPM and MEPM can be clinically useful drugs in the treatment of the disease due to M. abscessus.

摘要

为筛选治疗脓肿分枝杆菌所致疾病的有效药物,我们采用MGIT系统通过微量稀释法测定了8株临床分离的脓肿分枝杆菌对3种头孢菌素类药物[头孢他啶(CAZ)、头孢西丁(CFX)、氟氧头孢(FMOX)]和3种碳青霉烯类药物[亚胺培南(IPM)、帕尼培南(PAPM)、美罗培南(MEPM)]的最低抑菌浓度(MIC)。在所有8株菌株中,CAZ的MIC均高于32微克/毫升。CFX的MIC50、MIC90、MIC范围分别为32微克/毫升、>32微克/毫升和16->32微克/毫升,FMOX的分别为16微克/毫升、32微克/毫升和16-32微克/毫升;IPM的分别为8微克/毫升、16微克/毫升和8-16微克/毫升;PAPM的分别为4微克/毫升、16微克/毫升和4-16微克/毫升;MEPM的分别为8微克/毫升、16微克/毫升和8-16微克/毫升。从本研究得出结论,FMOX、IPM、PAPM和MEPM可作为治疗脓肿分枝杆菌所致疾病的临床有效药物。

相似文献

1
[Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus].[头孢菌素类和碳青霉烯类对临床分离脓肿分枝杆菌的活性]
Kekkaku. 2003 Sep;78(9):587-90.
2
[Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].美罗培南对临床分离菌株的抗菌活性。对从血液和脑脊液中分离出的菌株的结果
Jpn J Antibiot. 1996 Apr;49(4):377-85.
3
[Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].碳青霉烯类对铜绿假单胞菌的比较抗菌活性(1)
Jpn J Antibiot. 2001 Nov;54(11):571-9.
4
[Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].碳青霉烯类抗生素对革兰氏阴性杆菌的抗菌活性
Jpn J Antibiot. 1998 Sep;51(9):551-60.
5
[Evaluation of antibiotics by the method of initial bactericidal activity].[采用初始杀菌活性方法对抗生素进行评估]
Jpn J Antibiot. 2000 Dec;53(12):667-71.
6
[Antimicrobial activities of meropenem against clinically isolated strains in 1997].
Jpn J Antibiot. 1999 Dec;52(12):695-720.
7
[Antibacterial activity of biapenem against recent clinical isolates].[比阿培南对近期临床分离株的抗菌活性]
Jpn J Antibiot. 2003 Apr;56(2):138-41.
8
[Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].[2000年和2001年帕尼培南对临床分离株的抗菌活性]
Jpn J Antibiot. 2002 Dec;55(6):808-26.
9
[Antimicrobial activities of meropenem against clinically isolated strains].美罗培南对临床分离菌株的抗菌活性
Jpn J Antibiot. 1996 Feb;49(2):175-93.
10
Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.β-内酰胺酶的产生和β-内酰胺不稳定性对脓肿分枝杆菌 MIC 检测结果的影响。
J Antimicrob Chemother. 2017 Nov 1;72(11):3070-3078. doi: 10.1093/jac/dkx284.

引用本文的文献

1
and β-Lactams: Emerging Insights and Potential Opportunities.以及β-内酰胺类:新见解与潜在机遇
Front Microbiol. 2018 Sep 25;9:2273. doi: 10.3389/fmicb.2018.02273. eCollection 2018.
2
Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.阿维巴坦与碳青霉烯类药物联合使用对耐药脓肿分枝杆菌显示出增强的抗菌效力。
Future Microbiol. 2017 May;12(6):473-480. doi: 10.2217/fmb-2016-0234. Epub 2017 Feb 16.